Mecanismos moleculares asociados al síndrome metabólico
University of Edinburgh
Edimburgo, Reino UnidoPublicaciones en colaboración con investigadores/as de University of Edinburgh (6)
2019
-
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
The Lancet, Vol. 394, Núm. 10193, pp. 121-130
-
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
The Lancet, Vol. 394, Núm. 10193, pp. 131-138
2018
-
SIRT1 Controls Acetaminophen Hepatotoxicity by Modulating Inflammation and Oxidative Stress
Antioxidants and Redox Signaling, Vol. 28, Núm. 13, pp. 1187-1208
2016
2013
-
Protein tyrosine phosphatase 1B modulates GSK3b/Nrf2 and IGFIR signaling pathways in acetaminophen-induced hepatotoxicity
Cell Death and Disease, Vol. 4, Núm. 5